Today: 24 January 2026
Subscribe
Browse Category

Financial Analysis News 5 November 2025 - 6 November 2025

Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

What Vistra reported today Vistra posted third‑quarter 2025 GAAP net income of $652 million and Ongoing Operations Adjusted EBITDA of $1.581 billion. Management said the year‑over‑year decline in GAAP profit primarily reflects lower unrealized mark‑to‑market gains on hedging positions and the Martin Lake Unit 1 outage, partially offset by recognition of nuclear production tax credit revenue and firmer capacity prices.…
6 November 2025
···
Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) reported third‑quarter 2025 results this morning (Nov. 6), highlighting sequential revenue growth, materially higher gross margins, and steady commercial momentum for its tumor‑infiltrating lymphocyte (TIL) therapy Amtagvi. Management also reaffirmed full‑year revenue guidance and flagged pipeline milestones led by encouraging lung‑cancer data for lifileucel. GlobeNewswire What Iovance announced (Nov. 6, 2025) Revenue, margin, and guidance.…
6 November 2025
····
Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

What happened in Q3 Oscar Health reported third‑quarter revenue of $2,985,984,000 (in thousands), up from $2,423,482,000 a year ago—about 23% YoY growth, driven largely by higher membership. The medical loss ratio (MLR) increased to 88.5% (from 84.6%), which the company tied to a $130M net risk‑adjustment transfer accrual reflecting higher average market morbidity; this was partly offset by $84M of…
6 November 2025
···
Celsius Holdings (CELH) Q3 2025: Revenue Jumps 173% to $725.1M; GAAP Loss on Distribution Charges as PepsiCo Partnership Deepens

Celsius Holdings (CELH) Q3 2025: Revenue Jumps 173% to $725.1M; GAAP Loss on Distribution Charges as PepsiCo Partnership Deepens

At a glance (Q3 2025) Earnings headline: Big top‑line, accounting headwinds on the bottom line Celsius Holdings reported $725.1 million in Q3 sales, up 173% year over year, as the company’s broadened energy portfolio and expanded distribution powered growth. GAAP results swung to a $(0.27) diluted loss per share, primarily due to $246.7 million in distributor termination costs tied to…
6 November 2025
····
Datadog (DDOG) Jumps After Q3 2025 Beat: $886M Revenue, $0.55 EPS; Full‑Year Outlook Raised

Datadog (DDOG) Jumps After Q3 2025 Beat: $886M Revenue, $0.55 EPS; Full‑Year Outlook Raised

Cloud observability and security provider Datadog (NASDAQ: DDOG) posted a stronger‑than‑expected third quarter and lifted its full‑year guidance, citing continued momentum with large customers and rapid product innovation in AI observability and security. The company reported revenue of $886 million (+28% YoY) and non‑GAAP EPS of $0.55, both above Street expectations. Premarket, shares rose roughly 7% on the news. GlobeNewswire…
6 November 2025
····
Nasdaq Rally Amid Tech Frenzy: Markets Brush Off Shutdown Fears in Late September 2025

U.S. Stock Market Today (Nov. 6, 2025): Futures Mixed as Jobless Claims & Productivity Loom; Tesla Pay Vote, Airbnb & DraftKings Earnings in Focus

Here’s your fast, fact‑checked brief on what matters before the bell in the U.S. today (Thursday, Nov. 6, 2025). 1) Overnight & pre‑market snapshot 2) Today’s U.S. economic calendar (all times ET) Why it matters: Claims set the tone for labor‑market momentum; productivity and labor‑costs feed the inflation outlook that informs the Fed’s rate‑cut path into year‑end. Reuters 3) Earnings…
6 November 2025
····
DroneShield Stock Skyrockets 40%: What’s Behind the Surge and What’s Next?

DroneShield (ASX:DRO) tumbles as 31.16m new shares hit the market after option vesting — what today’s filings mean for investors (Nov 6, 2025)

Key points What happened today (Nov 6) DroneShield shares continued to feel the aftershocks of mid‑week filings. European quotations on Tradegate showed the stock lower by about 8.3% to €2.04 at 11:30 CET on Thursday, extending Wednesday’s weakness on the ASX. Finanznachrichten The slide follows confirmation that 31,161,833 new DroneShield shares were approved for quotation on 5 November. The ASX…
6 November 2025
···
Primerica (NYSE: PRI) Q3 2025 beats: EPS $6.35; revenue $839.9M; record $3.7B ISP sales as investors eye today’s earnings call

Primerica (NYSE: PRI) Q3 2025 beats: EPS $6.35; revenue $839.9M; record $3.7B ISP sales as investors eye today’s earnings call

Published November 6, 2025 DULUTH, Ga. — Primerica (NYSE: PRI) posted stronger‑than‑expected third‑quarter 2025 results after Wednesday’s close, setting fresh records in its Investment & Savings Products (ISP) business and topping Wall Street’s earnings and revenue forecasts ahead of its conference call this morning (10:00 a.m. ET, Nov. 6). Total revenue rose 8% year over year to $839.9 million, while…
6 November 2025
···
Nov. 6, 2025 — Lattice Semiconductor (LSCC) Matches Q3, Guides 22% Q4 Growth; Benchmark Electronics (BHE) Files 10‑Q After Mixed Quarter

Nov. 6, 2025 — Lattice Semiconductor (LSCC) Matches Q3, Guides 22% Q4 Growth; Benchmark Electronics (BHE) Files 10‑Q After Mixed Quarter

Updated Nov. 6, 2025 — Shares of Lattice Semiconductor (NASDAQ: LSCC) and Benchmark Electronics (NYSE: BHE) remain in focus today as investors digest fresh filings, analyst reactions, and guidance following this week’s earnings. Below we break down the key numbers, what changed today, and what to watch next. Key takeaways Lattice Semiconductor (LSCC): in‑line quarter, solid AI/data‑center tailwinds Lattice’s Q3…
6 November 2025
···
AMC Stock Today (Nov 5, 2025): Q3 Revenue Beats Estimates, Loss Widens; CEO Sees Best Q4 in Six Years

AMC Stock Today (Nov 5, 2025): Q3 Revenue Beats Estimates, Loss Widens; CEO Sees Best Q4 in Six Years

AMC Entertainment’s (NYSE: AMC) shares are in focus after the company posted third‑quarter results and struck an upbeat tone on year‑end box office momentum. What happened today AMC reported Q3 revenue of $1.30 billion, topping Wall Street’s ~$1.23 billion consensus, as summer and early fall releases kept moviegoers coming back. The company also booked a net loss of $298.2 million…
5 November 2025
··
IBM Stock Soars on AI, Quantum, and Cloud Hype – Is the Rally Sustainable?

IBM Stock Today (Nov. 5, 2025): Shares Tick Higher as Big Blue Confirms Q4 Layoffs and Unveils AI Partnership With Agassi Sports

Published: November 5, 2025 • Updated: 22:22 UTC IBM at a glance (intraday) Top takeaways for NYSE: IBM on November 5, 2025 What’s moving IBM today 1) Q4 workforce rebalancing keeps spotlight on margin mix Fresh reporting today reiterates IBM’s plan to cut thousands of roles in Q4 while keeping U.S. employment roughly flat year over year. Management frames the…
5 November 2025
·
Tesla’s Stock Skyrockets on AI Hype – Latest Price Jump, Earnings Shocks & Bold 2025 Forecasts

Tesla Stock Today (Nov. 5, 2025): TSLA Climbs Ahead of High‑Stakes Musk Pay Vote as Europe Sales Slide

Dateline: Nov. 5, 2025 — Tesla (NASDAQ: TSLA) shares advanced Wednesday as investors braced for a pivotal shareholder vote on CEO Elon Musk’s proposed pay package, even as fresh data showed sharp October sales declines in key European markets and a new lawsuit hit Tesla’s insurance arm. Market snapshot (intraday) What’s moving TSLA today 1) The Musk pay vote—“pay him…
5 November 2025
····
1 … 205 206 207 208 209 … 230

Stock Market Today

  • ALS Limited's Steady Dividends Reinforce Industrial Sector Appeal on ASX
    January 24, 2026, 1:06 AM EST. ALS Limited (ASX:ALQ) continues to attract investor attention through steady earnings growth, consistent dividend payouts and its established position in Australia's testing, inspection and analytical services sector. Inclusion in the ASX 100 elevates its profile among investors seeking reliable industrial exposures. The company's investment case rests on converting steady demand from mining, life sciences and industrial clients into dependable cash flow and dividends. However, ALS faces risks including a higher debt load, reliance on executing growth and acquisition strategies, and a stretched valuation with a premium earnings multiple. Diverse market views on fair value ranging from A$10.29 to over A$5,500 highlight investor uncertainty. Analysts urge scrutiny of these factors alongside growth prospects before investment decisions.
Go toTop